Prelude Therapeutics
PRLD
#8532
Rank
ยฃ0.19 B
Marketcap
ยฃ2.47
Share price
-0.77%
Change (1 day)
93.59%
Change (1 year)

EPS for Prelude Therapeutics (PRLD)

EPS in 2026 (TTM): -ยฃ0.70

According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ0.72. In 2025 the company made an earnings per share (EPS) of -ยฃ0.99 an increase over its 2024 EPS that were of -ยฃ1.28.

EPS history for Prelude Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.70-29.44%
2025-ยฃ0.99-23.21%
2024-ยฃ1.28-16.83%
2023-ยฃ1.54-17.21%
2022-ยฃ1.870.41%
2021-ยฃ1.86-46.71%
2020-ยฃ3.49435.92%
2019-ยฃ0.6586.09%
2018-ยฃ0.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-ยฃ1.03 43.62%๐Ÿ‡บ๐Ÿ‡ธ USA